Document Detail

The duration of non-rodent toxicity studies for pharmaceuticals. International Conference on Harmonication (ICH).
MedLine Citation:
PMID:  10416259     Owner:  NLM     Status:  MEDLINE    
At the present time, there are no uniform standards for the duration of non-rodent chronic toxicity studies. The European Union (EU) requires a 6-month non-rodent study. In Japan, a 6-month study is sufficient for most, but not all, compounds. The U.S. Food and Drug Administration (FDA) maintains its standard duration of 12 months for non-rodents, with 6-month studies accepted for some clinical indications on a case-by-case basis. To achieve harmonization on the duration of non-rodent toxicity studies, each member regulatory region (EU, U.S., and Japan) of the International Conference on Harmonization (ICH) collected non-rodent studies with significant new toxicological findings that had occurred after 6 months. An ICH expert working group was organized that included representatives from the regulatory authorities of each ICH region, to jointly review all available case studies for the purpose of arriving at a consensus on the best duration time for non-rodent toxicity studies. Eighteen case studies were identified and evaluated (16 original cases plus 2 additional FDA cases); most of the toxicities identified fell into the following categories: (1) toxicities identified at 6 months; (2) toxicities observed at 12 months, which were absent or considered isolated and not noteworthy findings at 6 months; (3) drug-related deaths or morbidity that occurred between 6 and 12 months, with a pattern of toxicity that permitted the interpolation of findings to an intermediate interval between 6 and 12 months; and (4) a shift in the dose response for toxicity with increasing duration of drug exposure. Of the 18 cases evaluated, 11 supported a study-duration of 9-12 months, 4 supported a duration of 12 months, and the 3 remaining cases indicated that a 6-month study would be adequate. The working group concluded that there was sufficient evidence to support a harmonized 9-month duration for non-rodent toxicity studies, which would be applicable for most categories of pharmaceuticals.
J J DeGeorge; L L Meyers; M Takahashi; J F Contrera
Related Documents :
18457699 - Immunologic reactions and endodontics: an online study guide.
23551579 - Benign cephalic histiocytosis: case report and review of the literature.
22173579 - The first record of a sauropod dinosaur from antarctica.
18855009 - Intraductal papillary neoplasm of the bile duct associated with clonorchis sinensis inf...
23122009 - Congenital self-healing reticulohistiocytosis: concern for a poor prognosis.
22439129 - Fibrochondrogenesis, an antenatal and postnatal correlation.
15372449 - Twin reversed arterial perfusion: report of four cases.
25024809 - Pyelonephritis can be a source of a life-threatening necrotizing myofasciitis.
15042859 - Vulvar rhabdomyosarcoma in a 15-year-old girl (case report).
Publication Detail:
Type:  Guideline; Journal Article; Review    
Journal Detail:
Title:  Toxicological sciences : an official journal of the Society of Toxicology     Volume:  49     ISSN:  1096-6080     ISO Abbreviation:  Toxicol. Sci.     Publication Date:  1999 Jun 
Date Detail:
Created Date:  1999-10-13     Completed Date:  1999-10-13     Revised Date:  2010-09-17    
Medline Journal Info:
Nlm Unique ID:  9805461     Medline TA:  Toxicol Sci     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  143-55     Citation Subset:  IM    
FDA Center for Drug Evaluation and Research, Office of Review Management, Rockville, MD 28057, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Drug Evaluation
Drug Toxicity
International Agencies*
International Cooperation
Time Factors
Toxicity Tests*
United States

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Acquired immune deficiency syndrome (AIDS) presenting as a nasal septal perforation.
Next Document:  Quantitative evaluation of alternative mechanisms of blood and testes disposition of di(2-ethylhexyl...